These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36865172)

  • 21. Estimating the Potential Public Health Value of BCG Revaccination.
    Clark RA; Sumner T; Weerasuriya CK; Bakker R; Scriba TJ; White RG
    J Infect Dis; 2024 Apr; ():. PubMed ID: 38568214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.
    Thacher EG; Cavassini M; Audran R; Thierry AC; Bollaerts A; Cohen J; Demoitié MA; Ejigu D; Mettens P; Moris P; Ofori-Anyinam O; Spertini F
    AIDS; 2014 Jul; 28(12):1769-81. PubMed ID: 24911353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis.
    Weerasuriya CK; Harris RC; Quaife M; McQuaid CF; White RG; Gomez GB
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33799544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M
    PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.
    Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K
    BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
    Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
    PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of tuberculosis vaccine candidates in low- and middle-income countries: a systematic review of randomised controlled clinical trials.
    Wilson L; Gracie L; Kidy F; Thomas GN; Nirantharakumar K; Greenfield S; Manaseki-Holland S; Ward DJ; Gooden TE
    BMC Infect Dis; 2023 Feb; 23(1):120. PubMed ID: 36829123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential impact of vaccination on tuberculosis burden in India: A modelling analysis.
    Arinaminpathy N; Rade K; Kumar R; Joshi RP; Rao R
    Indian J Med Res; 2023; 157(2&3):119-126. PubMed ID: 37202930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
    Portnoy A; Clark RA; Quaife M; Weerasuriya CK; Mukandavire C; Bakker R; Deol AK; Malhotra S; Gebreselassie N; Zignol M; Sim SY; Hutubessy RCW; Baena IG; Nishikiori N; Jit M; White RG; Menzies NA
    PLoS Med; 2023 Jan; 20(1):e1004155. PubMed ID: 36693081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Development of New TB Vaccines: Recent Advances and Next Steps.
    Hatherill M; White RG; Hawn TR
    Front Microbiol; 2019; 10():3154. PubMed ID: 32082273
    [No Abstract]   [Full Text] [Related]  

  • 33. Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.
    Harris RC; Sumner T; Knight GM; Evans T; Cardenas V; Chen C; White RG
    Lancet Glob Health; 2019 Feb; 7(2):e209-e218. PubMed ID: 30630775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCG vaccination in India and tuberculosis in children: newer facets.
    Udani PM
    Indian J Pediatr; 1994; 61(5):451-62. PubMed ID: 7744445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children?
    Rahman M; Sekimoto M; Hira K; Koyama H; Imanaka Y; Fukui T
    Prev Med; 2002 Jul; 35(1):70-7. PubMed ID: 12079443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination.
    Weerasuriya CK; Harris RC; McQuaid CF; Gomez GB; White RG
    PLoS Comput Biol; 2022 Apr; 18(4):e1010002. PubMed ID: 35452459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette-Guérin-Vaccinated Adults.
    van den Berg RA; De Mot L; Leroux-Roels G; Bechtold V; Clement F; Coccia M; Jongert E; Evans TG; Gillard P; van der Most RG
    Front Immunol; 2018; 9():564. PubMed ID: 29632533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.
    Kumarasamy N; Poongulali S; Bollaerts A; Moris P; Beulah FE; Ayuk LN; Demoitié MA; Jongert E; Ofori-Anyinam O
    Medicine (Baltimore); 2016 Jan; 95(3):e2459. PubMed ID: 26817879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    Nemes E; Geldenhuys H; Rozot V; Rutkowski KT; Ratangee F; Bilek N; Mabwe S; Makhethe L; Erasmus M; Toefy A; Mulenga H; Hanekom WA; Self SG; Bekker LG; Ryall R; Gurunathan S; DiazGranados CA; Andersen P; Kromann I; Evans T; Ellis RD; Landry B; Hokey DA; Hopkins R; Ginsberg AM; Scriba TJ; Hatherill M;
    N Engl J Med; 2018 Jul; 379(2):138-149. PubMed ID: 29996082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.
    Day CL; Tameris M; Mansoor N; van Rooyen M; de Kock M; Geldenhuys H; Erasmus M; Makhethe L; Hughes EJ; Gelderbloem S; Bollaerts A; Bourguignon P; Cohen J; Demoitié MA; Mettens P; Moris P; Sadoff JC; Hawkridge A; Hussey GD; Mahomed H; Ofori-Anyinam O; Hanekom WA
    Am J Respir Crit Care Med; 2013 Aug; 188(4):492-502. PubMed ID: 23306546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.